Management of Coronary Artery Disease in the Setting of Transcatheter Aortic Valve Replacement.

Aortic stenosis and coronary artery disease (CAD) frequently co-exist, as they share a common pathophysiology and risk factors. Due to lack of randomised controlled trials (RCTs) and exclusion of significant CAD in transcatheter aortic valve replacement (TAVR) trials, the optimal method of revascularisation of CAD in patients undergoing TAVR remains unknown. Observational studies and meta-analyses have shown varied results in outcomes for patients with CAD undergoing TAVR, and no significant difference in post-TAVR outcomes in patients who underwent revascularisation either prior to or during TAVR versus those who did not. However, some observational studies have shown that patients with lower residual SYNTAX score (rSS) post-revascularisation have better outcomes post-TAVR compared to those with higher rSS. RCTs are needed to clearly understand whether revascularisation is beneficial in these patients. Until then, management of CAD in patients undergoing TAVR must be individualised based on discussion with the heart team.

[1]  M. Khan,et al.  Meta-Analysis Comparing Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation With Versus Without Percutaneous Coronary Intervention. , 2019, The American journal of cardiology.

[2]  J. Leipsic,et al.  Transcatheter Aortic‐Valve Replacement with a Balloon‐Expandable Valve in Low‐Risk Patients , 2019, The New England journal of medicine.

[3]  Andrew S. Mugglin,et al.  Transcatheter Aortic‐Valve Replacement with a Self‐Expanding Valve in Low‐Risk Patients , 2019, The New England journal of medicine.

[4]  F. D’Ascenzo,et al.  Independent impact of extent of coronary artery disease and percutaneous revascularisation on 30-day and one-year mortality after TAVI: a meta-analysis of adjusted observational results. , 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[5]  Mauricio G. Cohen,et al.  To revascularize or not before transcatheter aortic valve implantation? , 2018, Journal of thoracic disease.

[6]  P. Serruys,et al.  Coronary Hemodynamics in Patients With Severe Aortic Stenosis and Coronary Artery Disease Undergoing Transcatheter Aortic Valve Replacement , 2018, JACC. Cardiovascular interventions.

[7]  T. Engstrøm,et al.  Coronary artery disease, revascularization, and clinical outcomes in transcatheter aortic valve replacement: Real‐world results from the East Denmark Heart Registry , 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[8]  B. Prendergast.  Faculty of 1000 evaluation for 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2018 .

[9]  I. Palacios,et al.  The Role of Impella for Hemodynamic Support in Patients With Aortic Stenosis , 2018, Current Treatment Options in Cardiovascular Medicine.

[10]  Samin K. Sharma,et al.  Coronary Angiography and Percutaneous Coronary Intervention After Transcatheter Aortic Valve Replacement. , 2018, Journal of the American College of Cardiology.

[11]  R. Kornowski,et al.  Impact of Coronary Artery Revascularization Completeness on Outcomes of Patients With Coronary Artery Disease Undergoing Transcatheter Aortic Valve Replacement: A Meta-Analysis of Studies Using the Residual SYNTAX Score (Synergy Between PCI With Taxus and Cardiac Surgery) , 2018, Circulation. Cardiovascular interventions.

[12]  M. Buchbinder,et al.  Effect of Mechanically Expanded vs Self-Expanding Transcatheter Aortic Valve Replacement on Mortality and Major Adverse Clinical Events in High-Risk Patients With Aortic Stenosis: The REPRISE III Randomized Clinical Trial , 2018, JAMA.

[13]  G. Nickenig,et al.  Impact of coronary artery disease in patients undergoing transfemoral transcatheter aortic valve implantation. , 2017, International journal of cardiology.

[14]  L. Svensson,et al.  Impact of Coronary Artery Disease on 30‐Day and 1‐Year Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement: A Meta‐Analysis , 2017, Journal of the American Heart Association.

[15]  Jeroen J. Bax,et al.  2017 ESC/EACTS Guidelines for the management of valvular heart disease. , 2017, European heart journal.

[16]  C. Vassanelli,et al.  Coronary Catheterization and Percutaneous Interventions After Transcatheter Aortic Valve Implantation. , 2017, The American journal of cardiology.

[17]  I. Palacios,et al.  Outcomes of hemodynamic support with Impella in very high-risk patients undergoing balloon aortic valvuloplasty: Results from the Global cVAD Registry. , 2017, International journal of cardiology.

[18]  I. Barbash,et al.  The Prognostic Effects of Coronary Disease Severity and Completeness of Revascularization on Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement. , 2017, JACC. Cardiovascular interventions.

[19]  J. Townend,et al.  Transcatheter Aortic Valve Implantation With or Without Percutaneous Coronary Artery Revascularization Strategy: A Systematic Review and Meta‐Analysis , 2017, Journal of the American Heart Association.

[20]  Andrew S. Mugglin,et al.  Surgical or Transcatheter Aortic‐Valve Replacement in Intermediate‐Risk Patients , 2017, The New England journal of medicine.

[21]  J. Dubois-Randé,et al.  Coronary Procedures After TAVI With the Self‐Expanding Aortic Bioprosthesis Medtronic CoreValve™, Not an Easy Matter , 2017, Journal of interventional cardiology.

[22]  K. Harjai,et al.  Impact of Coronary Artery Disease Severity Assessed With the SYNTAX Score on Outcomes Following Transcatheter Aortic Valve Replacement , 2017, Journal of the American Heart Association.

[23]  M. Russo,et al.  Impact of Coronary Artery Disease on Postoperative Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement (TAVR): Is Preoperative Coronary Revascularization Necessary? , 2016, The Journal of invasive cardiology.

[24]  J. Chambers,et al.  Coronary Physiology During Exercise and Vasodilation in the Healthy Heart and in Severe Aortic Stenosis. , 2016, Journal of the American College of Cardiology.

[25]  J. Davies,et al.  Assessment, treatment, and prognostic implications of CAD in patients undergoing TAVI , 2016, Nature Reviews Cardiology.

[26]  M. Mack,et al.  Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. , 2016, The New England journal of medicine.

[27]  S. Kapadia,et al.  Outcomes in Patients With Transcatheter Aortic Valve Replacement and Left Main Stenting: The TAVR-LM Registry. , 2016, Journal of the American College of Cardiology.

[28]  W. Banya,et al.  Management of concomitant coronary artery disease in patients undergoing transcatheter aortic valve implantation: the United Kingdom TAVI Registry. , 2015, International journal of cardiology.

[29]  Volker Klauss,et al.  Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial , 2015, The Lancet.

[30]  R. Kornowski,et al.  Effect of coronary artery disease severity and revascularization completeness on 2-year clinical outcomes in patients undergoing transcatether aortic valve replacement , 2015, Coronary artery disease.

[31]  C. Young,et al.  The effect of coronary artery disease defined by quantitative coronary angiography and SYNTAX score upon outcome after transcatheter aortic valve implantation (TAVI) using the Edwards bioprosthesis. , 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[32]  P. Wenaweser,et al.  Coronary artery disease severity and aortic stenosis: clinical outcomes according to SYNTAX score in patients undergoing transcatheter aortic valve implantation. , 2014, European heart journal.

[33]  S. Pocock,et al.  The percutaneous coronary intervention prior to transcatheter aortic valve implantation (ACTIVATION) trial: study protocol for a randomized controlled trial , 2014, Trials.

[34]  T. Sundt,et al.  2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[35]  Maurice Buchbinder,et al.  Transcatheter aortic-valve replacement with a self-expanding prosthesis. , 2014, The New England journal of medicine.

[36]  Y. Arbel,et al.  Comparison of early and late outcomes of TAVI alone compared to TAVI plus PCI in aortic stenosis patients with and without coronary artery disease , 2014, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[37]  A. Colombo,et al.  Impact of coronary artery disease in elderly patients undergoing transcatheter aortic valve implantation: insight from the Italian CoreValve Registry. , 2013, International journal of cardiology.

[38]  R. Schnabel,et al.  Mid-term prognostic value of coronary artery disease in patients undergoing transcatheter aortic valve implantation: a meta-analysis of adjusted observational results. , 2013, International journal of cardiology.

[39]  M. Mack,et al.  Quantification of Incomplete Revascularization and its Association With Five-Year Mortality in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) Trial Validation of the Residual SYNTAX Score , 2013, Circulation.

[40]  T. Mihaljevic,et al.  Coronary artery disease and outcomes of aortic valve replacement for severe aortic stenosis. , 2013, Journal of the American College of Cardiology.

[41]  G. Schuler,et al.  Transcatheter aortic valve implantation in patients with and without concomitant coronary artery disease: comparison of characteristics and early outcome in the German multicenter TAVI registry , 2012, Clinical Research in Cardiology.

[42]  P. Leprince,et al.  Registry of transcatheter aortic-valve implantation in high-risk patients. , 2012, The New England journal of medicine.

[43]  R. Hetzer,et al.  Combined elective percutaneous coronary intervention and transapical transcatheter aortic valve implantation. , 2012, Interactive cardiovascular and thoracic surgery.

[44]  E. Tuzcu,et al.  Percutaneous Coronary Intervention in Patients With Severe Aortic Stenosis: Implications for Transcatheter Aortic Valve Replacement , 2012, Circulation.

[45]  G. Richardt,et al.  Comparison of outcomes in patients having isolated transcatheter aortic valve implantation versus combined with preprocedural percutaneous coronary intervention. , 2012, The American journal of cardiology.

[46]  B. Iung,et al.  Impact of coronary artery disease on indications for transcatheter aortic valve implantation and on procedural outcomes. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[47]  P. Wenaweser,et al.  Impact of coronary artery disease and percutaneous coronary intervention on outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[48]  Stuart J Pocock,et al.  Transcatheter versus surgical aortic-valve replacement in high-risk patients. , 2011, The New England journal of medicine.

[49]  Olaf Franzen,et al.  First experience with transcatheter aortic valve implantation and concomitant percutaneous coronary intervention , 2011, Clinical Research in Cardiology.

[50]  R. Boone,et al.  Impact of coronary artery disease on outcomes after transcatheter aortic valve implantation , 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[51]  M. Mack,et al.  Effect of concomitant coronary artery disease on procedural and late outcomes of transcatheter aortic valve implantation. , 2010, The Annals of thoracic surgery.

[52]  Y. Başaran,et al.  Dipyridamole Myocardial Perfusion Tomography in Patients with Severe Aortic Stenosis , 2002, Cardiology.

[53]  Bonnie K. Lind,et al.  Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. , 1999, The New England journal of medicine.

[54]  A. Gown,et al.  Characterization of the Early Lesion of ‘Degenerative’ Valvular Aortic Stenosis: Histological and Immunohistochemical Studies , 1994, Circulation.

[55]  W. P. Harvey,et al.  Development and progression of aortic valve stenosis: Atherosclerosis risk factors—a causal relationship? a clinical morphologic study , 1991, Clinical cardiology.

[56]  J. Caro.  ESC/EACTS Guidelines on the management of valvular heart disease , 2012 .

[57]  H. Rockette,et al.  Diabetes and hypercholesterolemia among patients with calcific aortic stenosis. , 1984, Journal of chronic diseases.